Summary
The role of the basal cell layer in organogenesis, epithelial renewal and development of benign prostatic disorders is largely unknown. The objective of the present study was to investigate whether or not basal cells express the nuclear androgen receptor (AR). Computer-assisted image analyses of immunohistochemical double stainings were performed to localize AR and basal-cell-specific cytokeratins in identical sections. The results showed that the basal cells express nuclear AR widely in normal and hyperplastic conditions. When compared with the staining intensities detected in secretory luminal cells, the receptor was most frequently expressed at lower levels in basal cells, which may exhibit strong AR immunoreactivity focally. Basal cells with increased AR expression were most frequently detected in hyperplastic lesions including post-atrophic and atypical hyperplasia. The presence of nuclear receptors for both androgens and oestrogens or progestins in basal cells may indicate that these cells are targets of the hormonal imbalance which has frequently been implicated in the aetiology of benign prostatic hyperplasia.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Aumüller G (1983) Morphologic and endocrine aspects of prostatic function. Prostate 4:195
Bazer GT (1980) Basal cell proliferation and differentiation in regeneration of the rat ventral prostate. Invest Urol 17:470–473
Bonkhoff H, Wernert N (1989) Immunohistochemical analysis of the topographical relationship between the estrogen- and progesterone receptor in five human breast cancers. A simultaneous demonstration of both nuclear receptors in the same section by using a computer-assisted image processing. Virchows Arch [A] 414:339–344
Bonkhoff H, Wernert N, Dhom G, Remberger K (1991) Relation of endocrine-paracrine cells to cell proliferation in normal, hyperplastic and neoplastic human prostate. Prostate 19:91–98
Brandes D (1966) The fine structure and histochemistry of prostatic glands in relation to sex hormones. Int Rev Cytol 20:207–276
Dahl E, Kjaerheim A, Tveter KJ (1973) The ultrastructure of the accessory sex organs of the male rat. I. Normal structure. Z Zellforsch 137:345–359
Dermer GB (1978) Basal cell proliferation in benign prostatic hyperplasia. Cancer 41:1857–1862
English HF, Santen RJ, Isaacs JT (1987) Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement. Prostate 11:229–242
Evans GS, Chandler J (1987) Cell proliferation studies in rat prostate. I. The proliferative role of basal and secretory epithelial cells during normal growth. Prostate 10:163
Fickinger CJ (1971) Ultrastructural observations on the postnatal development of the rat prostate. Z Zellforsch 113:157–173
Fickinger CJ (1974) Protein secretion in the rat ventral prostate and the relation of Golgi vesicles, cisternae and vacuoles, as studied by electron microscope radioautography. Anat Rev 180:427–448
Heatfield BM, Sanefugi M, Trump BF (1982) Studies on carcinogenesis of human prostate. III. Long term explant culture of normal prostate and benign prostatic hyperplasia: transmission and scanning electron microscopy. J Natl Cancer Inst 69:757–766
Hedrich L, Epstein J (1989) Use of keratin 903 as an adjunct in the diagnosis of prostate carcinoma. Am J Surg Pathol 13:389–396
Isaacs JT, Coffey DS (1989) Etiology and disease process of benign prostatic hyperplasia. Prostate 2:33–50
Masai M, Sumiya H, Akimoto S, Yatani R, Chang C, Liao S, Shimazaki J (1990) Immunohistochemical study of androgen receptor in benign hyperplastic and cancerous human prostates. Prostate 17:293–300
Merchant DJ, Clarke SM, Ives K, Harris S (1983) Primary explant culture: an in vitro model of the human prostate. Prostate 4:523–542
Mobbs BG, Lin Y (1990) Immunohistochemical localization of progesterone receptor in benign and malignant human prostate. Prostate 16:245–251
Nicholson RI, Walter KJ, Davies P (1986) Hormone agonists and antagonists in the treatment of hormone sensitive breast and prostate cancer. Cancer Surv 5:463–486
Ruizeveld de Winter JA, Trapman J, Brinkmann AO, Boersma WJA, Mulder E, Schroeder FH, Claassen E, Kwast TH van der (1990) Androgen receptor heterogeneity in human prostatic carcinomas visualized by immunohistochemistry. J Pathol 161:329
Trump BF, Heatfield BM, Phelps PC (1981) In: Murphy GP, Sandberg AA, Karr JP (eds) The prostatic cell structure and function. Liss, New York, pp 25–53
Walsh PC (1989) Human benign prostatic hyperplasia: etiological considerations. In: Kimbale FA, Buhl AE, Carter DB (eds) New approaches to the study of benign prostatic hyperplasia. Liss, New York, pp 1–25
Wernert N, Seitz G, Achtstätter T (1987) Immunohistochemical investigations of different cytokeratins and vimentin in the prostate from fetal period up to adulthood and in prostate carcinoma. Pathol Res Pract 182:617–626
Wernert N, Gerdes J, Loy V, Seitz G, Scherr O, Dhom G (1988) Investigations of the estrogen (ER-ICA-test) and the progesterone receptor in the prostate and prostatic carcinoma on immunohistochemical basis. Virchows Arch [A] 412:387–391
Zegers ND, Claassen E, Neelen C, Mulder E, Van Laar JH, Voorhorst MM, Berrevoets CA, Brinkmann AO, Kwast TH van der, Ruizeveld de Winter JA, Trapman J, Boersma WJA (1991) Epitope prediction and confirmation for the human androgen receptor: generation of monoclonal antibodies for multi-assay performance following the synthetic peptide strategy. Biochem Biophys Acta 1073:23–32
Author information
Authors and Affiliations
Additional information
This study is dedicated to Professor Dhom on the occasion of his 70th birthday
Rights and permissions
About this article
Cite this article
Bonkhoff, H., Remberger, K. Widespread distribution of nuclear androgen receptors in the basal cell layer of the normal and hyperplastic human prostate. Vichows Archiv A Pathol Anat 422, 35–38 (1993). https://doi.org/10.1007/BF01605130
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01605130